Preclinical antibacterial products worldwide targeting priority pathogens 2021
In 2021, there were 28 antibacterial products in preclinical pipeline worldwide targeting mycobacterium tuberculosis. This statistic illustrates the number of preclinical antibacterial products worldwide targeting WHO priority single pathogens.